The Recall Desk
Agency classClass IIOur severity:SevereFDA (Drugs)·D-1317-2014·Announced 2014-05-21

Flawless Beauty Recalls Tatiomax Injection Vials Sold Without FDA Approval

Flawless Beauty LLC is recalling Tatiomax powder for injection vials because the product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classification is FDA Class II. According to the rubric, FDA Class II recalls are assigned a severity score of 4 (Severe), particularly when involving unapproved drug claims or significant regulatory violations.

Plain-English summary

Flawless Beauty LLC is recalling Tatiomax (reduced glutathione/hydrolyzed collagen) powder for injection vials, 1200 mg/200 mg, 10-count vials per box. The product was manufactured by Sujie Pharmaceutical Ltd. in Tokyo, Japan, and is identified by Lot # UB302 with an expiration date of 05/12/15. The recall is nationwide.

The recall was initiated because the product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). The source text notes that the product is sold over the counter and that its labeling includes drug claims to act as an antidote.

Consumers who have purchased this product should stop using it and contact the recalling firm for further instructions.

The recalled product

Product
Tatiomax (reduced glutathione/hydrolyzed collagen) powder for injection vials, 1200 mg/200 mg, 10-count vials per box, Manufactured by: Sujie Pharmaceutical Ltd., Tokyo, Japan, UPC 4973430081576

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot #: UB302
  • Exp 05/12/15

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 6 recalled by Flawless Beauty LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 6 products in this recall →

Similar recalls